Effective control of rush progression of CD8+ mycosis fungoides with pegylated interferon

Acta Derm Venereol. 2006;86(2):161-2. doi: 10.2340/00015555-0017.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • CD8-Positive T-Lymphocytes / pathology
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Mycosis Fungoides / immunology
  • Mycosis Fungoides / therapy*
  • Neoplasm Recurrence, Local / drug therapy*
  • Polyethylene Glycols / therapeutic use*
  • Radiotherapy, High-Energy
  • Recombinant Proteins
  • Skin Neoplasms / immunology
  • Skin Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • peginterferon alfa-2a